SCHEMBL5864264

SCHEMBL5864264

Cc1cc(Br)ccc1S(=O)(=O)N(Cc1cccc(O)c1)c1ccc(OCCN2CCCC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 3/20 0.48
MMP9 P14780 3/20 0.48
MMP13 P45452 3/20 0.48
ADAM17 P78536 2/20 0.48
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.41
PDK1 Q15118 2/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
LTA4H P09960 4/20 0.41
PTGS2 P35354 1/20 0.41
KDR P35968 2/20 0.40
ESR1 P03372 4/20 0.40
ESR2 Q92731 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5863870 0.92 MMP1 (0.44) MMP1MMP9MMP13ADAM17HTT
SCHEMBL5863938 0.91 MMP1 (0.42) MMP1MMP9MMP13ADAM17KDM4E
SCHEMBL5863988 0.91 MMP1 (0.54) MMP1MMP9MMP13ADAM17MEN1
SCHEMBL5864108 0.90 MMP1 (0.47) MMP1MMP9MMP13ADAM17HTT
SCHEMBL5863649 0.87 MMP1 (0.51) MMP1MMP9MMP13ADAM17KDM4E
SCHEMBL5863832 0.87 PDK1 (0.46) MMP1MMP9MMP13ADAM17HTT
SCHEMBL5864188 0.86 KDM4E (0.39) MMP1MMP9MMP13ADAM17KDM4E
SCHEMBL5863424 0.86 MMP1 (0.44) MMP1MMP9MMP13ADAM17HTT
SCHEMBL5863997 0.85 MMP1 (0.44) MMP1MMP9MMP13ADAM17MEN1
SCHEMBL5864079 0.85 PDK1 (0.46) MMP1MMP9MMP13ADAM17MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053212-B2 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC. (US) 2006-05-30 US disclosed
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor GHSR, GPER1, SSTR1 MMP1 1746/4885MMP9 2415/4885MMP13 2401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.